Results 51 to 60 of about 10,001 (276)
It is reasonable to treat patients with type 1 hepatorenal syndrome with midodrine and octreotide [PDF]
, 2016 A critical appraisal and clinical application of Esrailian E, Pantangco ER, Kyulo NL, Hu KQ, Runyon BA. Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci. 2007;
Kane, William
core +2 more sources
Indian Journal of Anaesthesia, 2015 Background and Aims: Liver disease is usually accompanied with a decline in systemic vascular resistance (SVR). We decided to assess effects of the peri-operative terlipressin infusion on liver donor liver transplantation recipients with respect to ...
Nagwa Ibrahim +7 more
doaj +1 more source
Gastro Hep Advances, 2023 Background and Aims: Type 1 hepatorenal syndrome (HRS) is a rapid deterioration in kidney function in patients with cirrhosis. Data on efficacy of vasoconstrictors for type 1 HRS have shown mixed results.
Ashwani K. Singal +4 more
doaj +1 more source
Iatrogenic bleeding during flexible bronchoscopy: risk factors, prophylactic measures and management. [PDF]
, 2017 Significant iatrogenic bleeding during flexible bronchoscopy is fortunately rare and usually self-limiting. Life-threatening bleeding, however, can occur, especially after conventional or cryoprobe-assisted transbronchial biopsy.
Breuer +27 more
core +3 more sources
The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome
Kidney360, 2023 Key Points Hepatorenal syndrome type 1 (HRS-1) is an often fatal, but potentially reversible, kidney failure in patients with decompensated cirrhosis. Treatment with terlipressin in patients with HRS-1 is associated with a reduction in the need for RRT ...
J. Velez +8 more
semanticscholar +1 more source
Journal of Pediatric and Neonatal Individualized Medicine, 2012 Terlipressin, a synthetic long-acting analogue of vasopressin, has been investigated as a second line vasopressor in adults and children with refractory septic shock, i.e.
Francesca Bissolo +5 more
doaj +1 more source
Two-component vasopressor therapy for septic shock
Вестник анестезиологии и реаниматологии, 2021 The objective: to investigate the efficacy and safety of terlipressin when it is used as an additional vasopressor in septic shock.Subjects: A single-center, observational, retrospective-prospective study of the efficacy and safety of combined therapy of
A. A. Kochkin +2 more
doaj +1 more source
The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score [PDF]
, 2014 Prognosis for patients with cirrhosis admitted to intensive care unit (ICU) is poor. ICU prognostic models are more accurate than liver-specific models.
Agarwal, B +6 more
core +1 more source
Angewandte Chemie, Volume 137, Issue 28, July 7, 2025.Targeting Amyloid‐β (Aβ) aggregation requires a peptide‐based approach that accounts for the structural heterogeneity of Aβ. Here, we employ topological reprogramming via disulfide bonds to stabilize antiparallel β‐sheets within the dimeric peptide.
Dongjoon Im +5 more
wiley +2 more sources
Current trends in vasopressor use to the operating room : a pharmacoepidemiologic study in French teaching and military hospitals [PDF]
, 2017 Objectives: Phenylephrine, ephedrine and norepinephrine are the vasopressors most commonly used in the operating room to treat anaesthesia-induced hypotension.
Armoiry, Xavier +4 more
core +2 more sources